A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical trial NCT02653976 · COMPLETED
Trial details
- NCT number
- NCT02653976
- Sponsor
- Solasia Pharma K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-25
- Primary completion
- 2020-10-11
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.